These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 22649138)
1. Increased body mass index is associated with improved survival in United States veterans with diffuse large B-cell lymphoma. Carson KR; Bartlett NL; McDonald JR; Luo S; Zeringue A; Liu J; Fu Q; Chang SH; Colditz GA J Clin Oncol; 2012 Sep; 30(26):3217-22. PubMed ID: 22649138 [TBL] [Abstract][Full Text] [Related]
2. Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma. Weiss L; Melchardt T; Habringer S; Boekstegers A; Hufnagl C; Neureiter D; Hopfinger G; Greil R; Egle A Ann Oncol; 2014 Jan; 25(1):171-6. PubMed ID: 24299961 [TBL] [Abstract][Full Text] [Related]
3. Body mass index as a prognostic factor in Asian patients treated with chemoimmunotherapy for diffuse large B cell lymphoma, not otherwise specified. Hwang HS; Yoon DH; Suh C; Huh J Ann Hematol; 2015 Oct; 94(10):1655-65. PubMed ID: 26174908 [TBL] [Abstract][Full Text] [Related]
4. The Prognostic Impact of Body Mass Index in Patients with Diffuse Large B-Cell Lymphoma: A Meta-Analysis. Wang Z; Luo S; Zhao X Nutr Cancer; 2021; 73(11-12):2336-2346. PubMed ID: 32964748 [TBL] [Abstract][Full Text] [Related]
5. Physical activity, obesity and survival in diffuse large B-cell and follicular lymphoma cases. Boyle T; Connors JM; Gascoyne RD; Berry BR; Sehn LH; Bashash M; Spinelli JJ Br J Haematol; 2017 Aug; 178(3):442-447. PubMed ID: 28466570 [TBL] [Abstract][Full Text] [Related]
6. Adolescent weight and height are predictors of specific non-Hodgkin lymphoma subtypes among a cohort of 2,352,988 individuals aged 16 to 19 years. Leiba M; Leiba A; Keinan-Boker L; Avigdor A; Derazne E; Levine H; Kark JD Cancer; 2016 Apr; 122(7):1068-77. PubMed ID: 26900677 [TBL] [Abstract][Full Text] [Related]
7. Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies. Castillo JJ; Ingham RR; Reagan JL; Furman M; Dalia S; Mitri J Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):122-30. PubMed ID: 24360912 [TBL] [Abstract][Full Text] [Related]
8. Body mass index and outcomes in patients receiving chemotherapy for intermediate-grade B-cell non-Hodgkin lymphoma. Jones JA; Fayad LE; Elting LS; Rodriguez MA Leuk Lymphoma; 2010 Sep; 51(9):1649-57. PubMed ID: 20807093 [TBL] [Abstract][Full Text] [Related]
9. Body mass index at diagnosis is associated with survival outcome in peripheral T-cell lymphoma: a study of Chinese population. Ma S; Zhao Y; Lu D; Ye X; Xie W Jpn J Clin Oncol; 2020 Feb; 50(2):169-174. PubMed ID: 31612913 [TBL] [Abstract][Full Text] [Related]
10. Obesity and non-Hodgkin lymphoma survival in an ethnically diverse population: the Multiethnic Cohort study. Leo QJ; Ollberding NJ; Wilkens LR; Kolonel LN; Henderson BE; Le Marchand L; Maskarinec G Cancer Causes Control; 2014 Nov; 25(11):1449-59. PubMed ID: 25070667 [TBL] [Abstract][Full Text] [Related]
11. Effect of body mass index on survival of patients with stage I non-small cell lung cancer. Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048 [TBL] [Abstract][Full Text] [Related]
12. High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex. Zhou Z; Rademaker AW; Gordon LI; LaCasce AS; Crosby-Thompson A; Vanderplas A; Abel GA; Rodriguez MA; Nademanee A; Kaminski MS; Czuczman MS; Millenson MM; Zelenetz AD; Niland J; Friedberg JW; Winter JN J Natl Compr Canc Netw; 2016 Oct; 14(10):1274-1281. PubMed ID: 27697981 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the prognostic value of BMI and the difference in its impact according to age and sex in DLBCL patients. Kanemasa Y; Shimoyama T; Sasaki Y; Tamura M; Sawada T; Omuro Y; Hishima T; Maeda Y Hematol Oncol; 2018 Feb; 36(1):76-83. PubMed ID: 28449294 [TBL] [Abstract][Full Text] [Related]
14. Body Mass Index Is Associated With All-cause Mortality After THA and TKA. Dowsey MM; Choong PFM; Paxton EW; Spelman T; Namba RS; Inacio MCS Clin Orthop Relat Res; 2018 Jun; 476(6):1139-1148. PubMed ID: 29775187 [TBL] [Abstract][Full Text] [Related]
15. Influence of body mass index on survival in veterans with multiple myeloma. Beason TS; Chang SH; Sanfilippo KM; Luo S; Colditz GA; Vij R; Tomasson MH; Dipersio JF; Stockerl-Goldstein K; Ganti A; Wildes T; Carson KR Oncologist; 2013; 18(10):1074-9. PubMed ID: 24048366 [TBL] [Abstract][Full Text] [Related]
16. Anthropometrics and prognosis in diffuse large B-cell lymphoma: a multicentre study of 653 patients. Bendtsen MD; Munksgaard PS; Severinsen MT; Bekric E; Brieghel C; Nielsen KB; Brown PN; Dybkaer K; Johnsen HE; Bøgsted M; El-Galaly TC Eur J Haematol; 2017 Apr; 98(4):355-362. PubMed ID: 27893172 [TBL] [Abstract][Full Text] [Related]
17. Overweight/obese status associates with favorable outcome in patients with metastatic nasopharyngeal carcinoma: a 10-year retrospective study. Li W; Shen LJ; Chen T; Sun XQ; Zhang Y; Wu M; Shu WH; Chen C; Pan CC; Xia YF; Wu PH Chin J Cancer; 2016 Aug; 35(1):75. PubMed ID: 27507261 [TBL] [Abstract][Full Text] [Related]
18. Higher body mass index is associated with reinterventions and lower maturation rates after upper extremity arteriovenous access creation. Raulli SJ; Sather K; Dicken QG; Farber A; Kalish JA; Eslami MH; Zhang Y; Cheng TW; Levin SR; Siracuse JJ J Vasc Surg; 2021 Mar; 73(3):1007-1015. PubMed ID: 32442609 [TBL] [Abstract][Full Text] [Related]
19. Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL). Griffiths R; Gleeson M; Knopf K; Danese M BMC Cancer; 2010 Nov; 10():625. PubMed ID: 21073707 [TBL] [Abstract][Full Text] [Related]
20. Improved survival in overweight and obese patients with aggressive B-cell lymphoma treated with rituximab-containing chemotherapy for curative intent. Stevenson JKR; Qiao Y; Chan KKW; Beca J; Isaranuwatchai W; Guo H; Schwartz D; Arias J; Gavura S; Dai WF; Kouroukis CT; Cheung MC Leuk Lymphoma; 2019 Jun; 60(6):1399-1408. PubMed ID: 30516081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]